Lonza Group Ltd. (SIX:LONN) CEO Marc Funk will leave the company in January for personal reasons. Chairman Albert Baehny will take on the CEO responsibilities on an interim basis. Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) said COO...

Medicxi’s newly closed third fund, its largest ever, will depart from the VC’s prior strategy by consolidating early and late stage investing into a single vehicle. Medicxi III will deploy €400 million ($451.2 million) across...

While Advent France Biotechnology and Medicxi are taking a wait-and-see approach with Yukin's kinase inhibitors targeting the NIK protein for cancer, the firms believe they could follow the biotech's €3.3 million ($3.7 million) seed round...